#Economy #StockMarket #InvestmentRisks
www.businessinsider.com
A top economist says markets and the economy have decoupled, and a damaging sell-off may be looming
Zandi said, "Falling asset prices threaten an already vulnerable economy. "
The stock market is wavering this year as investors fret over everything from tariffs to AI, but Mark Zandi thinks things could soon get a lot worse.
W
#PrivateCredit #InvestmentRisks #FinancialIndustry
www.wsj.com
Lloyd Blankfein Warns on Private Credit Going Mainstream
The turmoil at Blue Owl has raised new concerns about individuals investing in private-credit funds.
Former Goldman Sachs CEO Lloyd Blankfein weighed in on the risks inside private credit, especially as the industry aims to expand further with retail investors, in an interview with The Wall Street Journal earlier this month.
#PrivateCredit #FinancialCrisis #InvestmentRisk
markets.businessinsider.com
Mohamed El-Erian warns of financial-crisis red flags after a major private-credit fund freezes withdrawals
Mohamed El-Erian thinks a recent development in private credit contains echoes of the financial crisis.
In a LinkedIn post on Thursday, the former PIMCO CEO flagged a Financial Times report that said private credit giant Blue Owl Capital is permanently halting withdrawals in its Capital Corporation II fund, a private debt fund that's open to retail investors.
#AIBubble #TechValuation #InvestmentRisk
www.businessinsider.com
AI is a planet-sized bubble, Microsoft's stock drop is a warning of what's ahead: Gordon
The business professor has previously warned of extreme tech valuations and predicted harsh fallout.
Rampant speculation and massive overinvestment in AI have created a financial threat of cosmic proportions -- and the fallout will be catastrophic, Erik Gordon has warned.
#VaccinePolicy #PublicHealth #InvestmentRisks
www.aol.com
Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality
(Reuters) - Sweeping U. S. policy changes under Health Secretary Robert F. Kennedy Jr. are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes to inoculation schedules and recommendations, investors and executives said.
